发明名称 NOVEL TUMOUR SUPPRESSOR
摘要 A method of diagnosing cancer includes the steps of, in a sample obtained from a subject, determining the level or activity of HDAC2. A reduced level or activity of HDAC2 is indicative of cancer. HDAC2 protein expression is preferably determined. Indirect determination of HDAC2 expression is also possible, preferably by looking at the expression of genes selected from NCOA4, CTSB, TBCD, PPP2R4 and COROlC. Methods for predicting the probability of successful treatment of cancer using a hydroxamic acid based HDAC inhibitor and for selecting suitable cancer treatment regimens can also be based upon determining the level or activity of HDAC2. Methods of treatment of cancer may be based upon use of carboxylic acid based HDAC inhibitors or by reconstituting HDAC2 activity.
申请公布号 WO2007122369(A2) 申请公布日期 2007.11.01
申请号 WO2007GB01347 申请日期 2007.04.13
申请人 ONCOMETHYLOME SCIENCES SA;BALDOCK, SHARON, CLAIRE;ESTELLER, MANUEL 发明人 ESTELLER, MANUEL
分类号 G01N33/574;A61K31/19;A61K48/00 主分类号 G01N33/574
代理机构 代理人
主权项
地址